Risk for ESRD in type 1 diabetes remains high despite renoprotection

Journal of the American Society of Nephrology

Volumn 22, Issue 3, 2011, Pages 545-553

  Rosolowsky, Elizabeth T ^a,b,e   Skupien, Jan ^a,c   Smiles, Adam M ^a   Niewczas, Monika ^a,c   Roshan, Bijan ^a,c   Stanton, Robert ^a,c   Eckfeldt, John H ^d   Warram, James H ^a   Krolewski, Andrzej S ^a,c  

^a JOSLIN DIABETES CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID;

ADULT; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; DIABETIC PATIENT; DISEASE DURATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RENAL PROTECTION;

EID: 79952319585     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010040354     Document Type: Article

References (33)

1. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T: Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study. Diabetologia 25: 496-501, 1983 (Pubitemid 14200886)
2. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR: The changing natural history of nephropathy in type 1 diabetes. Am J Med 78: 785-794, 1985 (Pubitemid 15008233)
3. Borch-Johnsen K, Kreiner S: Proteinuria: Value as predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. BMJ 294: 1651-1654, 1987 (Pubitemid 17088017)
4. Mogensen CE: Long-term antihypertensive treatment inhibiting progression of DN. BMJ 285: 685-688, 1982
5. Parving HH, Andersen AR, Smidt UM, Svendsen PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in DN. Lancet 1: 1175-1179, 1983 (Pubitemid 13092704)
6. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. The Collaborate Study Group. N Engl J Med 329: 1456-1462, 1993 (Pubitemid 23335891)
7. Laffel LM, McGill JB, Gans DJ: The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group. Am J Med 99: 497-504, 1995
8. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342: 605-612, 2000
9. Limaye S, O'Kelly P, Harmon G, O'Neill D, Dorman AM, Walshe J, Donohoe J, Little D, Conlon PJ, Keogan MT: Improved graft survival in highly sensitized patients undergoing renal transplantation after the introduction of a clinically validated flow cytometry crossmatch. Transplantation 87: 1052-1056, 2009
10. Mange KC, Joffe MM, Feldman HI: Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med 344: 726-731, 2001 (Pubitemid 32204990)
11. Mange KC, Weir MR: Preemptive renal transplantation: Why not? Am J Transplant 3: 1336-1340, 2003 (Pubitemid 37288076)
12. Krolewski AS, Laffel LM, Krolewski M, Quinn M, Warram JH: Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 332(19): 1251-1255, 1995
13. Forsblom C, Harjutsalo V, Thorn LM, Wadén J, Tolonen N, Saraheimo M, Gordin D, Moran JL, Thomas MC, Groop P-H on behalf of the FinnDiane Study Group: Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol 22: 537-544, 2011
14. Jorsal A, Tarnow L, Flyvbjerg A, Parving HH, Rossing P, Rasmussen LM: Plasma osteoprotegerin levels predict cardiovascular and allcause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy. Diabetologia 51: 2100-2107, 2008
15. Parving HH, Jacobsen P, Rossing K, Smidt UM, Hommel E, Rossing P: Benefits of long-term antihypertensive treatment on prognosis on diabetic nephropathy. Kidney Int 49: 1778-1782, 1996 (Pubitemid 26186611)
16. Astrup AS, Ttarnow L, Rossing P, Pietraszek L, Hansen PR, Parving HH: Improved prognosis in type 1 diabetic patients with nephropathy: A prospective follow-up study. Kidney Int 68: 1250-1257, 2005 (Pubitemid 43246444)
17. Appel LJ, Wright JT Jr, Greene T, Kusek JW, Lewis JB, Wang X, Lipkowitz MS, Norris KC, Bakris GL, Rahman M, Contreras G, Rostand SG, Kopple JD, Gabbai FB, Schulman GI, Gassman JJ, Charleston J, Agodoa LY: Long-term effects of rennin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med 168: 832-839, 2008 (Pubitemid 351620085)
18. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, UKPDS Group: Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study. Kidney Int 63: 225-232, 2003 (Pubitemid 35463925)
19. DCCT/EDIC Research Group: Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Intervention and Complication (EDIC) study. JAMA 290: 2159-2167, 2003
20. Cantarovich D: Pancreas transplant alone, proposal of a new study: PANCREAStudy (Pancrease Allotransplanantion No Chronic Renal Ailure Study). Annual meeting of Euro. Soc. Organ Tansplant September 2007, Praha, Czech Republic
21. Fioretto P, Steffes MW, Southerland DE, Goetz FC, Mauer M: Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339: 69-75, 1998 (Pubitemid 28304880)
22. Ingelfinger JR: Aliskiren and dual therapy in type 2 diabetes mellitus. N Engl J Med 358: 2503-2505, 2008
23. Parving HH, Persson F, Lewis JB, Lewis EJ, Hollenberg NK: Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med 258: 2433-2446, 2008 (Pubitemid 351793017)
24. Tuttle KR: Protein kinase C-beta inhibition for diabetic kidney disease. Diabetes Res Clin Pract 82[Suppl 1]: S70-S74, 2008
25. Williams ME, Bolton WK, Khalifah RG, Degenhardt TP, Schotzinger RJ, McGill JB: Effects of pyrioxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy. Am J Nephrol 27: 605-614, 2007 (Pubitemid 350014947)
26. Deelman L, Sharma K: Mechanisms of kidney fibrosis and the role of antifibrotic therapies. Curr Opin Nephr Hypertension 18: 85-90, 2009
27. Brigstock DR: Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): From pharmacological inhibition in vitro to targeted siRNA therapy in vivo. J Cell Commun Signal 3: 5-18, 2009
28. Jones E, Pu H, Kyprianou N: Targeting TGF-beta in prostate cancer: Therapeutic possibilities during tumor progression. Expert Opin Ther Targets 13: 227-234, 2009
29. Becker BN, Rush SH, Dykstra DM, Becker YT, Port FK: Preemptive transplantation for patients with diabetes-related kidney disease. Arch Intern Med 166: 44-48, 2006 (Pubitemid 43063840)
30. Ficociello LH, Perkins BH, Silva KH, Finkelstein DM, Ignatowska-Switalska H, Gaciong Z, Cupples LA, Aschengrau A, Warram JH, Krolewski AS: Determinants of progression from microalbuminuria to proteinuria in type 1 diabetes patients treated with ACE Inhibitors. Clin J Am Soc Nephrol 2: 461-469, 2007
31. Warram JH, Gearin G, Laffel L, Krolewski AS: Effect of duration of IDDM on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol 7: 930-937, 1996 (Pubitemid 27465988)
32. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National Kidney Foundation. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Ann Intern Med 139: 137-147, 2003
33. Namboodiri K, Suchindran C: Life table techniques and their applications in studies in population, Orlando, Florida, Academic Press, 1987